Titanium Implant Device Registration Under New CMDE Guidelines in China

Titanium implant device registration is now subject to updated submission requirements issued on April 25, 2025, by China’s Center for Medical Device Evaluation (CMDE), under the National Medical Products Administration (NMPA). The new guidelines apply to titanium and titanium alloy bone implant medical devices and specify clearer technical expectations for test reports and mechanical property study materials—particularly for products with surface treatments such as colored and black anodization.

Background and Purpose of the New Regulations

Titanium and titanium alloy materials are widely used in orthopedic implant devices due to their excellent biocompatibility, high strength, and low modulus characteristics. However, surface treatment methods of these materials (such as no surface treatment, surface coloring, and black anodization) may affect their performance. To ensure the safety and effectiveness of these devices, Chinese regulatory authorities have issued clear guidelines for the submission of inspection and mechanical property study materials. The new regulations aim to standardize the registration process, improve evaluation efficiency, and ensure patient safety and health.

Requirements for Test Report Submission

• Colored Anodized Products as Typical Products: When titanium original color (no surface treatment) and surface colored anodized orthopedic implant products are registered together, companies can choose colored anodized products as typical products for inspection. This means that companies do not need to inspect each product with different surface treatment methods separately, thus saving time and costs. However, companies must ensure that the inspection results of the selected typical products can represent the performance of other products.
• Separate Inspections for Colored and Black Anodized Products: If colored anodized products and black anodized products are registered together, it is recommended to conduct separate inspections. This is because these two surface treatment methods may have different impacts on product performance. By conducting separate inspections, companies can more accurately assess the performance of each product and ensure compliance with Chinese registration requirements.

Requirements for the Submission of Mechanical Property Study Materials

• Reasonable Justification and Supporting Materials: For mechanical property study materials, if the applicant can reasonably justify that the colored and black anodized treatments have no significant impact on the mechanical properties of the products and provide corresponding supporting materials, they can choose one of the worst-case scenarios of surface treatment methods for mechanical property testing. This provision provides flexibility for companies but also requires sufficient technical support and justification capabilities. If justification is not reasonable, mechanical property study materials for both may need to be submitted.

Impact on International Companies

• Consideration of Time and Cost: On one hand, companies need to adjust their inspection and mechanical property study strategies according to the newly released regulatory requirements, which may require additional time and resources. On the other hand, the new regulations provide clearer guidance for companies, helping to reduce the risk of registration failure or delay due to non-compliance.
• Technical Support and Compliance: International companies need to ensure that their technical teams are familiar with China's regulatory requirements and have the corresponding technical support capabilities. This includes understanding of surface treatment methods for titanium and titanium alloy materials and how to conduct reasonable mechanical property justification and testing. Companies may need to cooperate with local regulatory experts or consulting agencies in China, such as Cisema, to ensure their products comply with China's registration requirements.

Positioning of This Newly Released Regulation in China's Regulatory Framework

• Integration with Existing Regulations: This newly released regulation is closely integrated with existing medical device registration regulations and standards, further detailing the registration requirements for titanium and titanium alloy bone implant devices. By specifying the submission guidelines for test reports and mechanical property study materials, it helps improve the transparency and efficiency of evaluation and provides a clearer direction for companies' registration applications.
• Key Changes and Trends: Compared with existing regulations, the new regulations place greater emphasis on the impact of product surface treatment methods on performance. This reflects the strict requirements of Chinese regulatory authorities on the safety and effectiveness of medical devices and the reference to international advanced regulatory experiences. The implementation of the new regulations also indicates that China's medical device market is moving towards a more standardized and internationalized direction.

Strategies for International Companies to Respond

• Early Planning and Preparation: International companies should understand and study China's new regulatory requirements in advance, combine their own product characteristics and technical strengths to develop corresponding registration strategies. This includes selecting appropriate typical products for inspection, preparing sufficient supporting materials, and reasonably arranging mechanical property testing plans.
• Strengthening Communication with the Chinese Market: Companies should actively communicate with Chinese regulatory authorities, regulatory experts, and consulting agencies to understand the details of the new regulations and evaluation key points in a timely manner. By closely connecting with the Chinese market, companies can better grasp market dynamics, adjust product strategies, and improve registration success rates.
• Continuous Attention to Regulatory Dynamics: China's medical device regulations are in a continuous process of updating and improvement. International companies should pay continuous attention to regulatory dynamics and adjust their compliance strategies in a timely manner. This not only helps companies maintain competitiveness in the market but also helps ensure that the safety and effectiveness of their products always comply with China's regulatory requirements.

Further Information

To read the original announcement about the submission guidelines for titanium and titanium alloy bone implant medical devices released by China’s Center for Medical Device Evaluation (CMDE), please click here.

If you are a medical device manufacturer with questions about how long it takes or how much it costs to register your titanium implant products for the China market, please contact Cisema.

GET IN TOUCH

🌐 Send us your enquiry

📚 Request our whitepapers

📣 Sign up for our newsletter